<DOC>
	<DOCNO>NCT00124553</DOCNO>
	<brief_summary>In past , nutritional management form cornerstone treatment type 2 diabetes ( T2DM ) . More recently , aspect treatment receive less attention drug therapy aim low glucose , also treat raise blood pressure blood fat ( include cholesterol ) widespread . While evidence suggest blood pressure blood fat level improve , overall diabetes control people diabetes appear become progressively overweight , follow trend general population . The propose study involve randomise controlled trial people T2DM continue regular drug treatment surveillance , randomly allocate additionally receive intensive advice regard diet remain usual treatment regard . The result judge principally term body weight , waist circumference , blood pressure , blood glucose control blood fat .</brief_summary>
	<brief_title>LOADD ( Lifestyle Over Above Drugs Diabetes ) Study</brief_title>
	<detailed_description>This 6-month pilot intervention study seek determine whether adherence intensive evidence base dietary programme , addition prescription cardioprotective hypoglycaemic medication recommend patient diabetes , provide health benefit term reduce risk develop progression complication diabetes ( particularly cardiovascular disease ) . The specific aim project compare effect intensive lifestyle intervention ( base recently publish evidence base recommendation Nutrition Study Group European Association Study Diabetes [ 3 ] ) usual dietary advice , diabetic patient high risk cardiovascular disease , treat cardioprotective hypoglycaemic drug . Study participant randomise two group : - The control group receive usual dietary advice diabetes treatment usual GP practice nurse ( detailed Management Type 2 Diabetes The Assessment Management Cardiovascular Risk guideline publish December 2003 [ 1,2 ] ) . - In addition usual care , intervention group receive intensive instruction recommend dietary pattern base recently publish recommendation Nutrition Study Group European Association Study Diabetes [ 3 ] appropriate use material , example serve size information mention guideline . Outcome determine examine surrogate marker clinical endpoint . These surrogate marker include clinical measure ( weight , body mass index , blood pressure ) appropriate test ( haemoglobin A1c , fast insulin , blood lipid , lipoprotein , inflammatory marker , urine albumin creatinine ratio ) . A quality life questionnaire also administer begin end project . 1 . New Zealand Guidelines Group . The assessment management cardiovascular risk . Wellington , NZ . December , 2003. http : //www.nzgg.org.nz 2 . New Zealand Guidelines Group . Management Type 2 diabetes . Wellington , NZ . December , 2003. http : //www.nzgg.org.nz 3 . Mann JI , De Leeuw I , Hermansen K , Karamanos B , Karlstrom B , Katsilambros N , Riccardi G , Rivellese AA , Rizkalla S , Slama G , Toeller M , Uusitupa M , Vessby B. Nutr Metab Cardiovasc Dis 14:373-394 , 2004</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes Resident Dunedin Aged &lt; 70 year time invitation participate Most recent HbA1c level within last 12 month ≥ 7 % Currently prescribe oral tablet insulin glycaemic control AND three follow : *Any preexist cardiovascular disease define past history myocardial infarction , angina , peripheral vascular disease , cerebrovascular accident , transient ischaemic attack ; *Currently prescribe antihypertensive medication ; *Currently prescribe lipid modify medication ; *Body mass index ≥25 Exclusion criterion : Terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>glycaemic control</keyword>
	<keyword>dietary modification</keyword>
</DOC>